期刊文献+

内皮细胞在涂层心血管植入物表面的生长:模似仿生性构建具有生物活性的细胞外基质 被引量:2

Growth of endothelial cell on the surface of intravascular stent material:Bionic construction of bioactive extracellular matrix
下载PDF
导出
摘要 背景:冠状动脉内置入药物涂层支架显著解决了支架内再狭窄,但是,支架内晚期及超晚期血栓带来新的难题加快支架内皮化,预防血栓形成成为研究的关键。目的:观察内皮细胞在经刻蚀并构建仿生的生物活性表面,整合细胞外基质成分的金属钛表面的生长情况。设计、时间及地点:对比观察,于2007-08/2009-01在西南交通大学先进材料与技术教育部重点实验室完成。材料:成年杂交犬6只,体质量15~20kg,纯钛(99.997%)为西安宝鸡有色金属有限公司产品,切割成5mm×5mm×2mm圆片试样。方法:在已刻蚀的钛表面通过自组装技术构建胶原-肝素-血管内皮生长因子-内皮祖细胞膜蛋白抗体为组分的多层膜作为涂层组;未涂层的钛为未涂层组。成年杂交犬6只,涂层组样品置入右侧股动脉,未涂层组置入左侧股动脉内,获得2h,15d,3个月的样品。主要观察指标:乳酸脱氢酶实验测定黏附血小板的数量;酶联免疫法测定GMP-140以检测黏附血小板激活程度;扫描电镜观察黏附血小板的形貌;采用SysmexCA-600凝血仪测定活化部分凝血活酶时间及凝血酶原时间。扫描电镜观察植入物在不同时间点,内皮细胞在其表面的生长;免疫荧光法观察置入2h的试片表面分化成熟的内皮细胞,其血管内皮生长因子受体2的表达。结果:①乳酸脱氢酶实验显示涂层样片的乳酸脱氢酶值比未涂层显著减少,说明涂层钛可以减少血小板的黏附(P<0.05)。②黏附血小板激活程度的定量分析结果显示在涂层上黏附血小板P-选择素的表达显著小于未涂层上的表达(P<0.05)。③扫描电镜可见涂层钛表面黏附血小板形貌的变形程度小于未涂层钛。④涂层的活化部分凝血活酶时间和凝血酶原时间分别是(134.2±13.3),(34.2±5.7)s;未涂层的活化部分凝血活酶时间和凝血酶原时间分别是(44.9±2.3),(17.3±2.4)s,可见涂层的凝血时间显著延长(P<0.05)。⑤扫描 BACKGROUND: Coronary artery drug-eluting stent implantation significantly resolves the in-stent restenosis. However, the late and very late in-stent thrombosis makes new problems. Accelerating stent endothelialization to prevent thrombosis is the key in related study. OBJECTIVE: To observe the growth and propagation of vascular endothelial cells (ECs) on the surface of intravascular stent material. DESIGN, TIME AND SETTING: Comparative observation was performed at the Key Laboratory of Advancad Materials Technology, Ministry of Education, Southwest Jiaotong University from August 2007 to January 2009. MATERIALS: Atotal of 6 adult hybrid dogs, weighing 15-20 kg, were used. Pure titanium (99.97%) was purchased from Xi'an Baoji Non-ferrous Metals, and cut into round samples, 5min×5mm×2mm. METHODS: The multilayer of collagen/heparin/vascular growth factor (VEGF)-endothelial progenitor cell membrane protein anti-cluster of differentiation 34(CD34) was constructed by a layer-by-layer self-assembly (LbL)on the surface of'litanium testing slice as coated group. Uncoated group was the bare Titanium testing slice. In 6 adult hybrid dogs, the coated group samples were inserted into the dght femoral artery, the uncoated group samples were inserted into the left femoral artery. The samples of 2 hours, 15 days and 3 months were harvested. MAIN OUTCOME MEASURES: Lactate dehydrogenase(LDH) experiment determined the number of platelet adhesion. Enzyme-linked immunosorbent assay was used to detect the degree of platelet-activating on adhesion. The morphology of adhesive platelet was tested by scanning electron microscope (SEM). Activated partial thromboplastin time (aPTT) and Prothrombin time (PT) tests were measured on Sysmex CA-600 Blood Coagulation Analyzer. SEM evaluated the growth on the surface of implant testing titanium slice at different time points. The expression of vascular endothelial growth factor receptor-2 (VEGF-R2) of maturation EC on the surface of testing
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第43期8425-8431,共7页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 “973”项目(国家重点基础研究发展计划《组织诱导性生物医用材料的基础研究》项目下属子项目“诱导抗凝血生物化表面的设计和构建”)(2005CB623904) 国家自然科学基金资助项目(20603027) 博士后基金资助项目(20060401019)~~
  • 相关文献

参考文献32

  • 1Thiele H, Oettel S, Jacobs S, et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up. Circulation. 2005; 112(22):3445-3450. 被引量:1
  • 2Marroquin OC, Seizer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008;358(4):342-352. 被引量:1
  • 3Simonton CA, Brodie B, Cheek B, et al. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. J Am Coll Cardiol. 2007;50(13):1214-1222. 被引量:1
  • 4Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998-1008. 被引量:1
  • 5James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009;360(19):1933-1945. 被引量:1
  • 6Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2003;107(1):24-27. 被引量:1
  • 7Thiele H, Neumann-Schniedewind P, Jacobs S, et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009;53(25):2324-2331. 被引量:1
  • 8Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002;106(21 ): 2649-2651. 被引量:1
  • 9Cosgrave J, Qasim A, Latib A, et al. Very late restenosis after paclitaxel-eluting stent implantation. Ann Intern Med. 2007; 147 (12):885-887. 被引量:1
  • 10Goy J J, Urban P, Kaufmann U, et al. Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice. Am Heart J. 2009; 157(5):883-888. 被引量:1

二级参考文献33

  • 1朱军慧,陶谦民,陈君柱,王兴祥,朱建华,尚云鹏.他汀类药物对外周血内皮祖细胞的影响(英文)[J].生理学报,2004,56(3):357-364. 被引量:16
  • 2Huang N,Yang P,Leng YX,et al.Hemocompatibility of titanium oxide films,Biomaterials,2003;24(13):2177 被引量:1
  • 3Huang N,Yang P,Cheng X,et al.Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition.Biomaterials,1998;19(7-9):771 被引量:1
  • 4Zhao AS,Yang P,Leng YX,et al.Research on platelet adsorption behavior using enzyme immunoassays and LDH testing.Key Engineering Materials,2005;288-289:515 被引量:1
  • 5Huang N,Yang P,Leng YX.Surface modification of biomaterials by plasma immersion ion implantation.Surface & Coatings Technology,2004; 186:218 被引量:1
  • 6Spijker HT,Bos R,Busscher HJ,et al.Platelets adhesion and activation on shielded plasma gradient prepared on polyethylene.Biomaterials,2002; 23(3):757 被引量:1
  • 7Sciedlecki CA,Wang IW,Higashi JM,et al.Platelet-derived microparticles on synthetic surface observed by atomic microscopy and fluorescence microscopy.Biomaterials,1999; 20(16):1521 被引量:1
  • 8Weber N,Wendel HP,Ziemer G.Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption.Biomaterials,2002; 23(2):429 被引量:1
  • 9Broberg M,Nygren H.Von Willebrand factor,a key protein in the exposure of CD62P on platelets.Biomaterials,2001; 22(17):2403 被引量:1
  • 10Julia EB, Anderson JM, Larry VM, et al. Host response to tissue engineered devices. Advanced Drug Delivery Reviews, 1998, 33:111 被引量:1

共引文献722

同被引文献35

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部